Day April 1, 2024

Interview with Stefany Shaheen: Revolutionizing diabetes care through cell therapies

I had the extraordinary opportunity to chat with Stefany Shaheen, the Chief Strategy Officer of Advanced Regenerative Manufacturing Institute (ARMI) and BioFab USA, about the transformative potential of cell therapies for individuals living with diabetes. Stefany shared her remarkable journey, insights on cell therapies' current status, approval challenges, and how the diabetes community can contribute to advancing research in this field.